Clinical factors and incidence of acute chest syndrome or pneumonia among children with sickle cell disease presenting with a fever: A 17-year review

Pediatric Emergency Care

Volumn 29, Issue 7, 2013, Pages 781-786

  Chang, Todd P ^a   Kriengsoontorkij, Worapant ^b   Chan, Linda S ^c   Wang, Vincent J ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c LAC USC MEDICAL CENTER   (United States)

Author keywords

acute chest; bacterial pneumonia; invasive pneumococcal disease; pneumonia; sickle cell; Streptococcus pneumoniae

Indexed keywords

HEMOGLOBIN; PENICILLIN DERIVATIVE;

ACUTE CHEST SYNDROME; FEVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MEDICATION COMPLIANCE; NEUTROPHIL COUNT; PNEUMONIA; RETROSPECTIVE STUDY; REVIEW; SECONDARY ANALYSIS; SEX DIFFERENCE; SICKLE CELL ANEMIA; UPPER RESPIRATORY TRACT INFECTION;

EID: 84880679865     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0b013e31829829f7     Document Type: Review

References (24)

1. Neumayr LD, Lennette ET, Kelly D, et al. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics. 2003;112: 87-95.
2. Vichinsky EP, Neumayr LD, Earles AN, et al., for the National Acute Chest Syndrome Study Group. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med 2000;342:1855-1865.
3. Adamkiewicz TV, Sarnaik S, Buchanan GR, et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr. 2003;143: 438-444.
4. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood. 1994;84:643-649.
5. Vichinsky EP, Styles LA, Colangelo LH, et al. The Cooperative Study of Sickle Cell Disease. Acute chest syndrome in sickle cell disease: clinical presentation and course. Blood. 1997;89:1789-1792.
6. Poulter EY, Truszkowski P, Thompson AA, et al. Acute chest syndrome is associated with history of asthma in hemoglobin SC disease. Pediatr Blood Cancer. 2011;57:289-293.
7. Miller ST, How I treat acute chest syndrome in children with sickle cell disease. Blood. 2011;117:5297-5305.
8. National Institute of Health. Infection. In: The Management of Sickle Cell Disease. 4th ed. 2002:75-79. Available at: http://www.nhlbi.nih.gov/health/ prof/blood/sickle/sc-mngt.pdf. Accessed June 2010.
9. Mart́i-Carvajal AJ, Conterno L. Antibiotics for treating community acquired pneumonia in people with sickle cell disease. Cochrane Database Syst Rev. 2006;3:CD005598.
10. Centers for Disease Control. Invasive pneumococcal disease in children 5 years after conjugate vaccine introductionVeight states 1998-2005. Morb Mortal Wkly Rep. 2008; 57(06): 144-148.
11. Zhou F, Kyaw MH, Shefer A, et al. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States. Arch Pediatr Adolesc Med. 2007;161:1162-1168.
12. Pilishvili T, Lexau C, Farley MM, et al., for the Active Bacterial Core Surveillance/Emerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201:32-41.
13. Grijalva CG, Nuorti JP, Arbogast PG, et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007;369:1179-1186.
14. Halasa NB, Shankar SM, Talbot T, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44:1428-1433.
15. Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373-1379.
16. Adamkiewicz TV, Silk BJ, Howgate J, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics. 2008;121:562-569.
17. Overturf GD. American Academy of Pediatrics Committee on Infectious Diseases, technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics. 2000;106(2 pt 1):367-376.
18. Centers for Disease Control. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccineVUnited States 2007. Morb Mortal Wkly Rep. 2010; 59: 253-257.
19. Poncz M, Kane E, Gill FM. Acute chest syndrome in sickle cell disease: etiology and clinical correlates. J Pediatr. 1985;107:861-866.
20. Sprinkle RH, Cole T, Smith S, et al. Acute chest syndrome in children with sickle cell disease. A retrospective analysis of 100 hospitalized cases. Am J Pediatr Hematol Oncol. 1986;8:105-110.
21. Taylor C, Carter F, Poulose J, et al. Clinical presentation of acute chest syndrome in sickle cell disease. Postgrad Med J. 2004;80:346-349.
22. Wong WY. Prevention and management of infection in children with sickle cell anaemia. Paediatr Drugs. 2001;3:793-801.
23. Buchanan ID, Woodward M, Reed GW. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Pediatr Blood Cancer. 2005;45:716-724.
24. West DC, Andrada E, Azari R, et al. Predictors of bacteremia in febrile children with sickle cell disease. J Pediatr Hematol Oncol. 2002; 24:279-283.